With growing interest in CBD amid expanding research and availability, many wonder about its forms. While CBD oil is popular, CBD flowers offer another versatile option for wellness.
In France, cannabis is classified as a narcotic and prohibited. However, current legislation targets products exceeding 0.2% THC, the psychotropic compound in cannabis.
Since 2018, cannabidiol (CBD)—known for its potential medicinal properties—has gained traction. With THC below 0.2%, CBD products exhibit virtually no psychotropic effects, fueling a surge in legal sales.
CBD oil dominates discussions, but flowers are widely available online and in stores. What sets them apart?
CBD oil is produced via decarboxylation (CO2 extraction), activating cannabis compounds. Flowers are ground, oven-heated, then infused in oil with water in a bain-marie for tens of minutes, followed by filtering. Solvent extraction is an alternative.
Flowers serve as the raw material, sourced from vetted hemp varieties grown by experts. For oil, place 3-4 drops sublingually, holding for 60 seconds up to three times daily. Flowers are best vaporized or brewed as tea.
Cultivating legal CBD hemp is a specialized profession. Sourcing from professionals ensures compliant, high-quality products. EU-grown options adhere to strict standards, free from chemicals, preservatives, or additives.
CBD oil and flowers deliver comparable effects and properties. Backed by studies, CBD is praised for anti-inflammatory and relaxing qualities, plus restoring bodily homeostasis, modulating serotonin, and easing anxiety in neuropathic pain.
Emerging research explores benefits like lowering blood pressure, cholesterol, and risks for cancer, epilepsy, autism, Parkinson's, Alzheimer's, and schizophrenia. It may also aid smoking cessation.
Pharmaceuticals like Cannador (for multiple sclerosis, anorexia, cancers), Sativex, and Epidiolex highlight CBD's role. In France, trials target chemotherapy side effects and neuropathic pain for symptom relief; Canada has approved such uses.
A 2019 University of Queensland study boosted CBD's profile, showing efficacy against boils and anthrax from antibiotic-resistant Staphylococcus aureus and Bacillus anthracis.
The WHO deems antimicrobial resistance a top global threat to health and food security, potentially causing 10 million deaths by 2050. CBD could emerge as a vital tool in this battle.
